News
India-ROK Pharma & Biopharma CEOs Conclave
- by Team ABLE - 16 Jul, 2021
10 ABLE member companies and top biotech companies in South Korea shared their capabilities in the segments of vaccines, biologics, cell and gene therapy and Med-tech & genomics at a special session organized by the Indian Embassy in Seoul and ABLE. The participating companies were: Biocon, Syngene International, Stempeutics, Biocon Biologics, Dr Reddy’s Laboratories, Immuneel Therapeutics and Wockhardt from the Indian side and SK Biosciences, LG Life Sciences, Daewong Pharmaceutical and Lab Genomics from Korea.
Asia’s Potential of Leading the Global Supply Chain of Vaccines & Biologics
